Table 3:

Association between Pelvic Floor Disorders and Bone Strength in Postmenopausal Women

	Combined TBS & BMD*		TBS only†		BMD only‡
	aOR	95% CI	aOR	95% CI	aOR	95% CI
Any UI	1.48	1.05–2.10	1.57	1.08–2.28	1.07	0.76–1.50
SUI	1.53	1.06–2.21	1.46	0.99–2.16	1.16	0.81–1.66
UUI	1.33	0.93–1.90	1.54	1.05–2.26	1.00	0.70–1.43
MUI	1.45	1.02–2.05	1.55	1.06–2.25	1.05	0.74–1.48
FI	1.13	0.78–1.65	1.10	0.73–1.65	1.11	0.76–1.61
POP	0.95	0.55–1.65	1.16	0.65–2.04	1.04	0.60–1.78

Bolded values indicate statistical significance.

Models adjusted for covariates potentially influencing the outcomes based on clinical risk factors and bivariate analyses

^*Adjusted for age (centered), obesity, race, hormone therapy, smoking, and vaginal delivery

^†Adjusted for age (centered), obesity, race, hormone therapy, smoking, vaginal delivery, pulmonary disease, and steroid use

^‡Adjusted for age (centered), obesity, race, hormone therapy, and vaginal delivery

TBS: Trabecular bone score

BMD: Bone mineral density

UI: Urinary incontinence

SUI: Stress urinary incontinence

UUI: Urgency urinary incontinence

MUI: Mixed urinary incontinence

FI: Fecal incontinence

POP: Pelvic organ prolapse